Litcius/Paper detail

A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis

Yuting Liu, Huihua Ding, Zemin Lin, Que Wang, Li Chen, Shuangshuang Liu, Xiaoqian Yang, Fenghua Zhu, Yue-teng Huang, Shiqi Cao, Fangming Yang, Zilan Song, Jian Ding, Meiyu Geng, Hua Xie, Ao Zhang, Shijun He, Jianping Zuo

2021Acta Pharmacologica Sinica29 citationsDOIOpen Access PDF

Topics & Concepts

Bruton's tyrosine kinaseRANKLPharmacologyOsteoclastIbrutinibArthritisRheumatoid arthritisMedicineCancer researchChemistryInflammationB cellImmunologyInternal medicineTyrosine kinaseReceptorAntibodyActivator (genetics)LeukemiaChronic lymphocytic leukemiaChronic Lymphocytic Leukemia ResearchImmunodeficiency and Autoimmune DisordersLymphoma Diagnosis and Treatment
A novel tricyclic BTK inhibitor suppresses B cell responses and osteoclastic bone erosion in rheumatoid arthritis | Litcius